...

Pfizer recalls all lots of anti-smoking drug over carcinogen presence




  • In Health
  • 2021-09-16 15:16:03Z
  • By Reuters
 

(Reuters) - Pfizer Inc said on Thursday it was recalling all lots of its anti-smoking treatment, Chantix, due to high levels of cancer-causing agents called nitrosamines in the pills.

The drugmaker paused distribution of the drug in June, and has already recalled a number of lots of the medicine so far.

Pfizer asked wholesalers and distributors on Thursday to stop the use and distribution of the tablets immediately.

The company said there was no immediate risk to patients

taking Chantix, but advised them to consult with their health care provider to check the availability of alternative treatments.

Chantix was approved by the FDA in May 2006 as a prescription medication to help adults aged 18 and over quit smoking and is typically used for 12 to 24 weeks.

(Reporting by Amruta Khandekar; Editing by Saumyadeb Chakrabarty)

COMMENTS

More Related News

Statins may slightly lower COVID-19 death risk; using a different vaccine as booster may offer more protection
Statins may slightly lower COVID-19 death risk; using a different vaccine as booster may offer more protection
  • US
  • 2021-10-15 18:17:02Z

Widely-used statin drugs for lowering cholesterol may be linked to a slightly lower risk of dying from COVID-19, new data suggest. Researchers at Karolinska...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Health